S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
NYSEAMERICAN:IBIO

iBio News Headlines

$0.80
-0.05 (-5.88 %)
(As of 10/22/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.78
$0.85
50-Day Range N/A
52-Week Range
$0.78
$2.83
Volume6.02 million shs
Average Volume8.95 million shs
Market Capitalization$174.36 million
P/E RatioN/A
Dividend YieldN/A
Beta-6.24

Media Mentions By Week

iBio Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IBIO
News Sentiment

0.59

0.39

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IBIO Articles
This Week

1

4

IBIO Articles
Average Week

Get iBio News Delivered to You Automatically

Sign up to receive the latest news and ratings for IBIO and its competitors with MarketBeat's FREE daily newsletter.

iBio (NYSEAMERICAN IBIO) News Headlines Today

SourceHeadline
nasdaq.com logoNew Strong Sell Stocks for October 20th - Nasdaq
nasdaq.com - October 20 at 12:12 PM
benzinga.com logoIs iBio (AMEX: IBIO) Stock a Good Buy? • Benzinga - Benzinga
benzinga.com - October 12 at 2:16 PM
seekingalpha.com logoIBIO is at high risk of performing badly - Seeking Alpha
seekingalpha.com - October 6 at 11:02 AM
MarketBeat logoBrokers Set Expectations for iBio, Inc.'s FY2022 Earnings (NYSEAMERICAN:IBIO)
americanbankingnews.com - October 6 at 9:00 AM
seekingalpha.com logoWarning: IBIO has been downgraded to Very Bearish - Seeking Alpha
seekingalpha.com - October 5 at 6:46 AM
fool.com logoThis Under-the-Radar Pharma Company Could Be a Bargain Hunter's Dream - Motley Fool
fool.com - October 2 at 9:00 AM
finance.yahoo.com logoThis Under-the-Radar Pharma Company Could Be a Bargain Hunter's Dream
finance.yahoo.com - October 2 at 9:00 AM
benzinga.com logoWorldwide Plant Based Biomanufacturing Industry to 2026 - Featuring Pfizer, Aimmune Therapeutics and Medi - Benzinga
benzinga.com - September 27 at 5:33 PM
benzinga.com logoEarnings Scheduled For September 27, 2021 - Benzinga
benzinga.com - September 27 at 5:33 PM
finance.yahoo.com logoiBio Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Corporate Update - Yahoo Finance
finance.yahoo.com - September 27 at 12:32 PM
nasdaq.com logoIBio Reports Profit In Q4 - Quick Facts - Nasdaq
nasdaq.com - September 27 at 9:24 AM
globenewswire.com logoiBio Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Corporate Update - GlobeNewswire
globenewswire.com - September 27 at 8:27 AM
feeds.benzinga.com logoiBio Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Corporate Update
feeds.benzinga.com - September 27 at 8:09 AM
markets.businessinsider.com logoiBio earnings: here's what Wall Street expects
markets.businessinsider.com - September 27 at 1:36 AM
finance.yahoo.com logoiBio to Participate in the Cantor 2021 Virtual Global Healthcare Conference
finance.yahoo.com - September 20 at 6:14 PM
globenewswire.com logoiBio to Report Fiscal Fourth Quarter and Full Year 2021 Financial Results and Provide Corporate Update - GlobeNewswire
globenewswire.com - September 20 at 8:13 AM
finance.yahoo.com logoiBio to Report Fiscal Fourth Quarter and Full Year 2021 Financial Results and Provide Corporate Update on Monday, September 27, 2021
finance.yahoo.com - September 20 at 8:13 AM
marketwatch.com logoiBio Inc. stock remains steady Friday, still outperforms market - MarketWatch
marketwatch.com - September 10 at 9:59 PM
globenewswire.com logoiBio Announces Participation in HC Wainwright 23rd Annual Global Investment Conference - GlobeNewswire
globenewswire.com - September 7 at 5:01 PM
finance.yahoo.com logoiBio Announces Participation in H.C. Wainwright 23rd Annual Global Investment Conference
finance.yahoo.com - September 7 at 5:01 PM
marketwatch.com logoiBio Inc. stock rises Wednesday, outperforms market - MarketWatch
marketwatch.com - September 1 at 11:02 PM
marketwatch.com logoiBio Inc. stock remains steady Tuesday, still outperforms market - MarketWatch
marketwatch.com - August 31 at 8:43 PM
marketwatch.com logoiBio Inc. stock rises Friday, outperforms market - MarketWatch
marketwatch.com - August 28 at 1:27 AM
streetinsider.com logoForm 8-K iBio, Inc. For: Aug 23 - StreetInsider.com
streetinsider.com - August 27 at 3:24 PM
seekingalpha.com logoiBio adds William Clark to board of directors - Seeking Alpha
seekingalpha.com - August 26 at 5:31 PM
marketwatch.com logoiBio Inc. stock falls Thursday, underperforms market - MarketWatch
marketwatch.com - August 26 at 5:31 PM
globenewswire.com logoiBio Appoints William D. Clark to its Board of Directors - GlobeNewswire
globenewswire.com - August 26 at 7:30 AM
finance.yahoo.com logoiBio Appoints William D. Clark to its Board of Directors
finance.yahoo.com - August 26 at 7:30 AM
finance.yahoo.com logoiBio Expands Immuno-Oncology Pipeline With RubrYc Deal
finance.yahoo.com - August 25 at 3:33 PM
globenewswire.com logoiBio Expands Immuno-Oncology Pipeline in AI Partnership - GlobeNewswire
globenewswire.com - August 25 at 8:24 AM
finance.yahoo.com logoiBio Expands Immuno-Oncology Pipeline in AI Partnership with RubrYc Therapeutics
finance.yahoo.com - August 25 at 8:24 AM
marketwatch.com logoiBio Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
marketwatch.com - August 10 at 5:40 PM
marketwatch.com logoiBio Inc. stock remains steady Thursday, underperforms market - MarketWatch
marketwatch.com - August 5 at 6:05 PM
marketwatch.com logoiBio Inc. stock remains steady Monday, underperforms market - MarketWatch
marketwatch.com - August 2 at 10:24 PM
seekingalpha.com logoiBio says successful in preclinical studies for subunit COVID-19 vaccine candidate - Seeking Alpha
seekingalpha.com - July 16 at 5:14 PM
streetinsider.com logoiBio, Inc. (IBIO) Successful Preclinical Immunization Studies with Next-Gen Nucleocapsid COVID-19 Vaccine Candidate - StreetInsider.com
streetinsider.com - July 15 at 11:07 PM
finance.yahoo.com logoiBio Reports Successful Preclinical Immunization Studies with Next-Gen Nucleocapsid COVID-19 Vaccine Candidate - Yahoo Finance
finance.yahoo.com - July 15 at 8:33 PM
globenewswire.com logoiBio Reports Successful Preclinical Immunization Studies with Next-Gen Nucleocapsid COVID-19 Vaccine Candidate - GlobeNewswire
globenewswire.com - July 15 at 6:06 PM
finance.yahoo.com logoiBio Reports Successful Preclinical Immunization Studies with Next-Gen Nucleocapsid COVID-19 Vaccine Candidate
finance.yahoo.com - July 15 at 6:06 PM
markets.businessinsider.com logoIBio Stock Ticks Higher After Adding Three Cancer Antibody Programs - Markets Insider
markets.businessinsider.com - July 10 at 8:25 AM
finance.yahoo.com logoIBio Stock Ticks Higher After Adding Three Cancer Antibody Programs
finance.yahoo.com - July 9 at 9:34 AM
benzinga.com logoIBio Stock Ticks Higher After Adding Three Cancer Antibody Programs - Benzinga
benzinga.com - July 9 at 7:51 AM
streetinsider.com logoAfter-Hours Stock Movers 07/08: (LMPX) (LPTH) (IBO) Higher; (SGH) (DCT) Lower (more...) - StreetInsider.com
streetinsider.com - July 8 at 9:38 PM
finance.yahoo.com logoiBio Establishes Oncology Drug Discovery Pipeline with Three New Antibody Programs - Yahoo Finance
finance.yahoo.com - July 8 at 4:37 PM
finance.yahoo.com logoiBio Establishes Oncology Drug Discovery Pipeline with Three New Antibody Programs
finance.yahoo.com - July 8 at 4:37 PM
streetinsider.com logo8 Reddit Penny Stocks to Watch With Meme Stocks on the Rise - StreetInsider.com
streetinsider.com - June 30 at 6:48 AM
finance.yahoo.com logoIs IBIO Stock A Buy Here? - Yahoo Finance
finance.yahoo.com - June 18 at 11:58 PM
finance.yahoo.com logoIs IBIO Stock A Buy Here?
finance.yahoo.com - June 18 at 11:58 PM
streetinsider.com logoBest Biotech Penny Stocks to Buy? 3 to Watch Before Monday - StreetInsider.com
streetinsider.com - June 11 at 2:23 PM
finance.yahoo.com logoiBio Further Strengthens Board with Appointment of Veteran Biopharmaceutical Executive, Eef Schimmelpennink
finance.yahoo.com - June 9 at 5:46 PM
Get iBio News Delivered to You Automatically

Sign up to receive the latest news and ratings for IBIO and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 10/23/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.